SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors reaffirmed confidence in deramiocel and its FDA application in final review ahead of the November 22 decision have fueled attention, alongside an analyst upgrade. Many traders read CEO Linda Marbns comments about labeling and launch preparations as encouraging, but others stress that approval remains uncertain and a rejection could sharply reverse sentiment; short-squeeze speculation is also prominent.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Traders are focused on MoonLakes sonelokimab pipeline, especially the upcoming FDA decision on whether to accept its hidradenitis suppurativa BLA and whether it will receive priority review; positive Phase 3 psoriatic-arthritis results are also cited as support for the broader pipeline. Sentiment is divided between optimism about the drugs potential and concern about FDA risk, commercialization costs, and whether MoonLake can succeed without a partner or buyout.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles quarterly resultsrecord revenue and its first positive adjusted EBITDA, driven largely by Quake AIare fueling a bullish reassessment of its AI-infrastructure expansion. Traders are also debating whether growth can overcome GAAP losses, cash needs, a softer next-quarter outlook and possible data-center delays; short-squeeze claims remain speculative.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A broad rebound in AI and semiconductor stocks, fueled by CoreWeaves results easing concerns about AI infrastructure demand and financing, has lifted AMD sharply. Traders also point to money rotating from Nvidia amid leadership and China-related headlines, while debate centers on whether the rally has further momentum or is overextended and due for a pullback.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

BRUN is drawing attention ahead of its Q3 results, as traders anticipate proof that its AI cloud contracts can translate into revenue and cash flow; upbeat sentiment around CoreWeave and other neocloud peers is also fueling hopes for a sector rebound. Bulls see recovery potential after the steep selloff, while skeptics remain concerned about execution, financing, and volatility across AI infrastructure stocks.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras positive Phase 2 results for ABCL635, its investigational treatment for menopausal hot flashes, are driving attention, alongside analyst upgrades and enthusiasm over pipeline expansion. Traders are broadly optimistic but debate the stocks volatile pullbacks and are watching for longer-term data and a Phase 3 plan to validate the promise.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Hot U.S. inflation data and renewed Fed rate-hike bets have pressured gold as traders cite higher Treasury yields and a stronger dollar. The community is split between buyers looking for a rebound and bears warning that the selloff may continue.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos reported quarterly results and strong AI-networking demand are drawing attention, with traders weighing whether data-center orders can sustain growth or reflect a temporary buildout cycle. The reaction is mixed: some see a re-rating opportunity, while others remain cautious about margins and the durability of AI-related spending.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves stronger-than-expected quarterly results, raised outlook and record backlog have fueled a sharp rally, with traders also citing the CEOs canceled stock-sale plan and discussing a possible short squeeze. Bullish momentum is met with concerns about the companys heavy debt, capital spending and potential dilution.

GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF

GraniteShares 2x Long NVDA Daily ETF

NVDL is drawing attention as traders seek leveraged exposure to Nvidias swings, with many buying dips and trading around earnings amid optimism about AI demand. Others are cautious about the ETFs amplified downside and volatility decay, making the bullish positioning a point of debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TSLA Unlike the last delivery report, there has been no rally heading into the report tomorrow, so either a positive outcome is not priced in, or a negative outcome is priced in, imo. So either there&#39;s not much movement tmrw if the numbers are not great, or the stock shoots up if there&#39;s a positive surprise beat.

Elsa Assefa

StockTwits Web

 Unlike the last delivery report, there has been no rally heading into the report tomorrow, so either a positive outcome is not priced in, or a negative outcome is priced in, imo. So either there's not much movement tmrw if the numbers are not great, or the stock shoots up if there's a positive surprise beat.